173 related articles for article (PubMed ID: 32458466)
1. Clinical characteristics of hidradenitis suppurativa patients in Okinawa, Japan: Differences between East Asia and Western countries.
Omine T; Miyagi T; Hayashi K; Yamaguchi S; Takahashi K
J Dermatol; 2020 Aug; 47(8):855-862. PubMed ID: 32458466
[TBL] [Abstract][Full Text] [Related]
2. Demographic and clinical features of hidradenitis suppurativa in Korea.
Yang JH; Moon J; Kye YC; Kim KJ; Kim MN; Ro YS; Park MY; Ahn HH; Lee MW; Lee WJ; Lee JH; Lee JB; Jang MS; Choi YS; Choi YW; Suh DH;
J Dermatol; 2018 Dec; 45(12):1389-1395. PubMed ID: 30294846
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa in South-East Asia and East Asia.
Chandran NS; Lee JH; Kurokawa I
Exp Dermatol; 2021 Jun; 30 Suppl 1():23-26. PubMed ID: 34085331
[TBL] [Abstract][Full Text] [Related]
4. Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries.
Hayama K; Fujita H; Hashimoto T; Terui T;
J Dermatol; 2020 Jul; 47(7):743-748. PubMed ID: 32441411
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study.
Lee JH; Kwon HS; Jung HM; Kim GM; Bae JM
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1784-1790. PubMed ID: 29761904
[TBL] [Abstract][Full Text] [Related]
6. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics of Hidradenitis Suppurativa Patients from a Reference Centre in Kaunas, Lithuania.
Kucinskiene V; Jariene V; Valiukeviciene S
Dermatology; 2020; 236(1):66-70. PubMed ID: 31940646
[TBL] [Abstract][Full Text] [Related]
8. Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
Pinter A; Sarlak M; Zeiner KN; Malisiewicz B; Kaufmann R; Romanelli M; Koenig A; Chiricozzi A
Dermatology; 2021; 237(5):759-768. PubMed ID: 33326954
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and comorbidity of hidradenitis suppurativa in Korea for 17 years: A nationwide population-based cohort study.
Lee JW; Heo YW; Lee JH; Lee S
J Dermatol; 2023 Jun; 50(6):778-786. PubMed ID: 36806098
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of permanent stoma in Crohn's disease associated with hidradenitis suppurativa: a case-control study.
Dumont LM; Landman C; Sokol H; Beaugerie L; Cosnes J; Seksik P; Guégan S;
Aliment Pharmacol Ther; 2020 Jul; 52(2):303-310. PubMed ID: 32525586
[TBL] [Abstract][Full Text] [Related]
11. Adolescent-Onset Hidradenitis Suppurativa: Prevalence, Risk Factors and Disease Features.
Molina-Leyva A; Cuenca-Barrales C
Dermatology; 2019; 235(1):45-50. PubMed ID: 30368494
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of hidradenitis suppurativa in Taiwan: A 14-year nationwide population-based study.
Liang YT; Yeh CJ; Huang JY; Wei JC
J Dermatol; 2021 May; 48(5):613-619. PubMed ID: 33626195
[TBL] [Abstract][Full Text] [Related]
13. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
[TBL] [Abstract][Full Text] [Related]
14. Color Doppler ultrasound assessment of morphology and types of fistulous tracts in hidradenitis suppurativa (HS).
Wortsman X; Castro A; Figueroa A
J Am Acad Dermatol; 2016 Oct; 75(4):760-767. PubMed ID: 27498279
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of hidradenitis suppurativa.
Bukvić Mokos Z; Markota Čagalj A; Marinović B
Clin Dermatol; 2023; 41(5):564-575. PubMed ID: 37696341
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa.
Dessinioti C; Tzanetakou V; Zisimou C; Kontochristopoulos G; Antoniou C
Int J Dermatol; 2018 Jun; 57(6):687-691. PubMed ID: 29604044
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin Levels and Serum C-Reactive Protein in Patients With Moderate to Severe Hidradenitis Suppurativa.
Huang CM; Lowes MA; Cserti C; Alavi A
J Cutan Med Surg; 2019; 23(5):501-506. PubMed ID: 31253065
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
Peterson GC; Preston A; Frieder J; Wang X; Paek SY
Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
[TBL] [Abstract][Full Text] [Related]
19. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
Hessam S; Sand M; Gambichler T; Bechara FG
J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.
Canoui-Poitrine F; Revuz JE; Wolkenstein P; Viallette C; Gabison G; Pouget F; Poli F; Faye O; Bastuji-Garin S
J Am Acad Dermatol; 2009 Jul; 61(1):51-7. PubMed ID: 19406505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
